{"id":"W2161254226","doi":"10.1007/s00467-011-1894-x","title":"Should we consider MMF therapy after rituximab for nephrotic syndrome?","year":2011,"lang":"en","type":"letter","venue":"Pediatric Nephrology","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Rituximab; Nephrology; Nephrotic syndrome; Cyclophosphamide; Mycophenolate; Internal medicine; Drug; Clinical trial; Intensive care medicine; Maintenance therapy; Oncology; Pharmacology; Chemotherapy; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339905,0.0007771564,0.001507579,0.0008815579,0.003643469,0.002497781,0.001428409,0.03547288,0.006691272],"category_scores_gemma":[0.01643993,0.0005558769,0.001753822,0.0006116565,0.002013115,0.00364159,0.001025471,0.02112419,0.002609669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003128207,"about_ca_system_score_gemma":0.002420216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002766502,"about_ca_topic_score_gemma":0.005549201,"domain_scores_codex":[0.9984456,0.0004504337,0.0002955693,0.0001894062,0.0002909833,0.000328069],"domain_scores_gemma":[0.9951149,0.00255179,0.0005021367,0.0001451816,0.0005013001,0.001184669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004533346,0.0003840247,0.02811846,0.0004179449,0.000216475,0.4582224,0.0004664885,0.0008985117,0.001457629,0.006761291,0.4560736,0.04652985],"study_design_scores_gemma":[0.0006419531,0.0005385596,0.0171795,0.001784256,0.0003264327,0.5777828,0.001946136,0.002884854,0.001263155,0.0218725,0.3735861,0.0001939142],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.01258791,0.008870599,0.0005356527,0.9460995,0.01574704,0.00003588105,0.00006544938,0.00007806305,0.01597996],"genre_scores_gemma":[0.1327375,0.009502013,0.002586073,0.7328005,0.1129888,0.00008716813,0.000118174,0.00007065947,0.009109061],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03547288,"threshold_uncertainty_score":0.02269679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04435941131371676,"score_gpt":0.2839114140383888,"score_spread":0.239552002724672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}